Pesquisar | metanaruay

adicionou um novo artigo สุขภาพและความงาม

2026-03-18 10:11:57 -

Gastrointestinal Therapeutics Market: How Are JAK Inhibitors Reshaping UC and Crohn's Treatment?

JAK inhibitor therapies for inflammatory bowel disease represent the most significant recent pharmacological advance in IBD treatment, with the Gastrointestinal Therapeutics Market reflecting the approvals of tofacitinib, upadacitinib, and filgotinib for ulcerative colitis and upadacitinib's recent approval for Crohn's disease that have established small-molecule oral therapy as a meaningful...

0 ความคิดเห็น 0 แชร์ 279 ยอดวิว 0 รีวิว